Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,229 | 34,466 | 58,802 | 79,558 | 130,104 |
| Marketable Securities | 135,262 | 195,604 | 215,403 | 243,740 | 137,765 |
| Receivables | 10,038 | 26,379 | 25,347 | 20,199 | 18,192 |
| Other current assets | 14,444 | 12,905 | 19,472 | 19,479 | 16,082 |
| TOTAL | $186,516 | $281,281 | $331,967 | $373,752 | $313,237 |
| Non-Current Assets | |||||
| PPE Net | 101,874 | 104,855 | 107,515 | 111,017 | 114,497 |
| Investments And Advances | 0 | 10,785 | 27,838 | 40,296 | 4,858 |
| Other Non-Current Assets | 53,504 | 56,111 | 57,883 | 55,962 | 58,337 |
| TOTAL | $155,378 | $171,751 | $193,236 | $207,275 | $177,692 |
| Total Assets | $341,894 | $453,032 | $525,203 | $581,027 | $490,929 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,207 | 21,358 | 22,266 | 21,655 | 19,044 |
| Accrued Expenses | 21,892 | 38,390 | 38,316 | 35,557 | 23,597 |
| Other current liabilities | 14,225 | 39,609 | 41,718 | 40,302 | 42,560 |
| TOTAL | $71,110 | $118,095 | $124,568 | $119,540 | $106,731 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,919 | 10,452 | 13,195 | 13,977 | 13,588 |
| Other Non-Current Liabilities | 226,926 | 213,261 | 217,997 | 224,004 | 83,704 |
| TOTAL | $249,702 | $232,204 | $239,183 | $247,808 | $110,001 |
| Total Liabilities | $320,812 | $350,299 | $363,751 | $367,348 | $216,732 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,698 | 51,613 | 50,623 | 50,514 | 50,160 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -1,216,078 | -1,126,027 | -1,058,878 | -996,937 | -926,066 |
| Other shareholders' equity | -870 | -687 | -652 | -750 | -762 |
| TOTAL | $21,082 | $102,733 | $161,452 | $213,679 | $274,197 |
| Total Liabilities And Equity | $341,894 | $453,032 | $525,203 | $581,027 | $490,929 |